Progressive Supranuclear Palsy - 21 Studies Found
| Enrolling by invitation |
: Extension Study of BMS-986168 in Patients With Progressive Supranuclear Palsy Who Participated in CN002003 : Progressive Supranuclear Palsy : 2016-01-13 : Drug: BMS-986168 Same dose as corresponding CN002003 study panel. |
| Active, not recruiting |
: Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear Palsy : Progressive Supranuclear Palsy : 2015-05-20 :
|
| Completed |
: A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy. : Progressive Supranuclear Palsy : 2008-01-14 :
|
| Completed |
: Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy : Progressive Supranuclear Palsy : 2010-01-13 :
|
| Completed |
: Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy :
: 2016-03-31 :
|
| Completed |
: Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP) :
: 2006-09-28 : Drug: CoenzymeQ10 active drug Other Name: CoQ10 |
| Completed |
: Postural Instability in Progressive Supranuclear Palsy :
: 2012-03-22 |
| Completed |
: Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy : Supranuclear Palsy, Progressive : 2005-08-30 : Drug: donepezil |
| Completed |
: AMX0035 and Progressive Supranuclear Palsy : Progressive Supranuclear Palsy : 2025-08-01 : Proprietary formulation of sodium phenylbutyrate and taurursodiol |
| COMPLETED |
: Personalized Parkinson Project PSP Cohort : Progressive Supranuclear Palsy : 2025-08-01 : The Verily Study Watch is a smartwatch, collecting physiological and/or environmental information.The sensors collect data that include mov |